SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-025179
Filing Date
2019-12-03
Accepted
2019-12-03 07:40:27
Documents
7
Period of Report
2019-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k120219_intecpharma.htm 8-K 38080
2 OPINION OF MEITAR LIQUORNIK GEVA LESHEM TAL, ISRAELI LEGAL COUNSEL TO THE REGIST f8k120219ex5-1_intec.htm EX-5.1 15512
3 ORDINARY SHARES PURCHASE AGREEMENT, DATED DECEMBER 2, 2019 BETWEEN INTEC PHARMA f8k120219ex10-1_intec.htm EX-10.1 151247
4 REGISTRATION RIGHTS AGREEMENT, DATED DECEMBER 2, 2019, BETWEEN INTEC PHARMA LTD. f8k120219ex10-2_intec.htm EX-10.2 79573
5 PRESS RELEASE DATED DECEMBER 3, 2019, TITLED "INTEC PHARMA ANNOUNCES $10 MILLION f8k120219ex99-1_intec.htm EX-99.1 16308
6 GRAPHIC ex5-1_001.jpg GRAPHIC 51819
7 GRAPHIC ex99-1_001.jpg GRAPHIC 9994
  Complete submission text file 0001213900-19-025179.txt   387295
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37521 | Film No.: 191264648
SIC: 2834 Pharmaceutical Preparations